Bioter S.A. (BIOT) - Total Liabilities

Latest as of December 2022: €191.26 Million EUR ≈ $223.60 Million USD

Based on the latest financial reports, Bioter S.A. (BIOT) has total liabilities worth €191.26 Million EUR (≈ $223.60 Million USD) as of December 2022. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Bioter S.A. - Total Liabilities Trend (2014–2022)

This chart illustrates how Bioter S.A.'s total liabilities have evolved over time, based on quarterly financial data. Explore BIOT long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Bioter S.A. Competitors by Total Liabilities

The table below lists competitors of Bioter S.A. ranked by their total liabilities.

Company Country Total Liabilities
Alvo Minerals Ltd
AU:ALV
Australia AU$471.67K
Aurora Investment Trust plc
LSE:ARR
UK GBX442.00K
Pool Safe Inc
V:POOL
Canada CA$2.20 Million
Property Franchise Group PLC
LSE:TPFG
UK GBX51.32 Million
Absolicon Solar Collector AB Series B
ST:ABSL-B
Sweden Skr5.47 Million
Odd Burger Corp
V:ODD
Canada CA$6.70 Million
H&T Group plc
LSE:HAT
UK GBX98.53 Million
Sherpa II Holdings Corp
V:SHRP
Canada CA$290.13K

Liability Composition Analysis (2014–2022)

This chart breaks down Bioter S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Bioter S.A. asset portfolio.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.15 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.00 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.80 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 2.25 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bioter S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bioter S.A. (2014–2022)

The table below shows the annual total liabilities of Bioter S.A. from 2014 to 2022.

Year Total Liabilities Change
2022-12-31 €191.26 Million
≈ $223.60 Million
+5.53%
2021-12-31 €181.24 Million
≈ $211.89 Million
+4.21%
2020-12-31 €173.93 Million
≈ $203.34 Million
-4.33%
2019-12-31 €181.79 Million
≈ $212.53 Million
+5.83%
2018-12-31 €171.77 Million
≈ $200.82 Million
+6.53%
2017-12-31 €161.24 Million
≈ $188.50 Million
+11.15%
2016-12-31 €145.06 Million
≈ $169.59 Million
+7.32%
2015-12-31 €135.16 Million
≈ $158.02 Million
-6.32%
2014-12-31 €144.29 Million
≈ $168.69 Million
--

About Bioter S.A.

AT:BIOT Greece Engineering & Construction
Market Cap
$4.03 Million
€3.45 Million EUR
Market Cap Rank
#29237 Global
#111 in Greece
Share Price
€0.21
Change (1 day)
+0.00%
52-Week Range
€0.21 - €0.21
All Time High
€0.58
About

Bioter S.A. operates as a technical construction company in Greece and internationally. The company is involved in the execution of various projects, such as roads, ports, industrial-energy, electromechanical-communications, airports, war industries factories, etc., as well as private projects, such as offices, banks, bus stations, etc. The company was founded in 1961 and is based in Athens, Gree… Read more